hepat
c
viru
hcv
major
caus
bloodborn
chronic
hepat
potenti
progress
cirrhosi
infect
around
million
peopl
global
due
heterogen
hcv
protein
high
mutat
rate
complex
pathogenesi
approv
vaccin
human
applic
viral
infect
avail
date
recognit
conserv
epitop
hcv
protein
advanc
formul
vaccin
novel
modal
howev
led
placement
hcv
vaccin
pipelin
human
clinic
trial
recent
year
hcv
hold
singlestrand
positivesens
rna
genom
encod
three
structur
core
protein
envelop
protein
six
nonstructur
protein
among
hcv
protein
core
hcvcp
conserv
hcv
antigen
henc
good
candid
consid
hcv
vaccin
formul
accordingli
applic
even
isol
hcvcpctl
epitop
amino
acid
context
synthet
multiepitop
hcv
vaccin
also
report
besid
anticor
antibodi
first
rais
onset
infect
properti
provid
import
diagnost
valu
protein
locat
among
antibodycaptur
antigen
commerci
avail
serolog
assay
hcv
diagnosi
addit
nucleotid
sequenc
hcvcp
suppos
encod
altern
frameshift
protein
arfp
import
pathogen
role
chronic
hcv
infect
cirrhosi
therefor
fulfil
differ
diagnost
research
therapeut
demand
product
hcvcp
variou
express
system
address
howev
sinc
ctermin
hydrophob
region
hcvcp
exert
immunesuppress
effect
first
ntermin
residu
hydrophil
region
hcvcp
contain
nuclear
local
signal
nl
conserv
b
cell
epitop
usual
employ
differ
diagnost
vaccin
applic
plant
extens
potenti
provid
safe
inexpens
sourc
biopharmaceut
vaccin
protein
current
sever
plantderiv
viral
protein
hepat
b
surfac
antigen
norwalk
viru
capsid
protein
vaccin
clinic
trial
recent
invent
transgen
tobacco
plant
express
hcvcp
stabli
gener
direct
express
acid
ntermin
tobacco
chloroplast
report
although
prior
report
prove
proper
antigen
structur
plantderiv
hcvcp
diagnost
purpos
indic
full
function
react
polymonoclon
anticor
antibodi
hcvinfect
human
sera
howev
studi
address
transgen
stabl
tobacco
plant
gener
hcvcp
howev
transient
express
plant
compar
transgen
plant
gener
current
method
choic
due
sever
advantag
like
simplic
feasibl
rapid
protein
express
omit
tissu
cultur
regener
cost
eas
larg
scale
industri
plan
import
exampl
transient
express
plant
product
season
influenza
vaccin
tobacco
success
effici
plant
transient
express
howev
depend
sever
factor
codonoptim
heterolog
gene
accord
plantcodon
adapt
index
select
proper
express
vector
effici
inhibit
gene
silenc
phenomenon
suppress
express
foreign
gene
plant
present
knowledg
techniqu
abovement
paramet
improv
provid
novel
data
transient
express
process
regionallyadapt
plant
host
gener
overcom
plantbas
gene
silenc
phenomenon
specif
high
import
studi
aim
core
plasmid
encod
hcvcp
use
sourc
sequenc
construct
plantbas
express
vector
express
ntermin
hcvcp
protein
strain
escherichia
coli
arabinos
induct
posit
control
previous
describ
sever
modif
optim
plant
codonusag
hcvcp
nucleotid
sequenc
consid
includ
plantoptim
hcvcp
gene
recombin
express
tobacco
also
term
trhcvcp
synthes
deliv
clone
plasmid
shinegen
molecular
biotech
inc
shanghai
china
shown
figur
synthet
gene
subclon
bamhi
saci
site
vector
control
camv
promot
upstream
nopalin
synthas
transcript
termin
noster
studi
pvxgw
vector
kindli
gift
dr
cristiano
lacort
embrapa
recurso
genetico
e
biotecnologia
brazil
use
pvxbase
viral
vector
clone
trhcvcp
sequenc
pvxgw
vector
synthet
gene
pcr
amplifi
use
forward
primer
fkozakvx
revers
primer
rcorevx
harbor
clai
sali
restrict
site
underlin
sequenc
pcr
amplif
perform
cycl
second
second
second
minut
amplicon
subsequ
digest
clai
sali
enzym
clone
site
pvxgw
vector
control
duplic
pvx
coat
protein
subgenom
promot
cpp
figur
b
recombin
construct
confirm
restrict
sequenc
analys
use
fkozakvx
rcorevx
specif
primer
clone
molecular
procedur
accord
standard
protocol
tumefact
strain
transform
pvxcore
pbicor
vector
figur
separ
reaction
via
standard
freezethaw
protocol
end
hcvcpcode
plant
construct
pbicor
pvxcore
introduc
agrobacterium
case
pbicor
agrobacterium
latter
alreadi
harbor
helper
plasmid
psoup
case
pvxcore
essenti
replic
pvxgwbase
plasmid
agrobacterium
speci
respect
subsequ
transform
agrobacterium
cell
select
plate
contain
rifampicin
rif
kanamycin
kan
incub
hour
transform
coloni
confirm
genespecif
coloni
pcr
use
fkozakvx
rcorevxspecif
primer
describ
chemic
cultur
media
antibiot
purchas
sigma
us
merck
germani
compani
inhibit
silenc
foreign
gene
express
tobacco
construct
express
vector
coinfiltr
agrobacterium
strain
harbor
silencingsuppressor
gene
tomato
bushi
stunt
viru
tbsv
genbank
access
number
previous
clone
pcambia
vector
cambia
co
australia
lab
vector
agroinfiltr
protocol
accord
kapila
et
al
studi
brief
agrobacterium
cultur
first
adjust
od
ms
medium
supplement
wv
sucros
mm
me
ph
mm
induc
addit
hour
acetosyringon
agrobacterium
suspens
subsequ
mix
equal
ratio
half
plasmid
half
express
construct
either
pvxcore
pbicor
n
tabacum
cultivar
jafarabadi
kindli
provid
dr
tohidfar
agricultur
biotechnolog
research
institut
iran
leav
immers
bacteri
suspens
vacuum
mbar
appli
two
minut
infiltr
leav
place
adaxi
side
wet
whatman
paper
glass
contain
subsequ
incub
photoperiod
five
day
infiltr
tobacco
leav
ground
fine
powder
liquid
nitrogen
use
mortar
pestl
subsequ
extract
buffer
mm
ph
mm
nacl
tween
mm
betamercaptoethanol
mm
pmsf
mm
edta
ad
gram
powder
leaf
tissu
total
solubl
protein
tsp
remov
cell
debri
centrifug
leaf
extract
minut
rpm
e
colideriv
hcvcp
ehcvcp
plantderiv
hcvcp
phcvcp
purifi
applic
nickelnitrilotriacet
acid
ninta
chromatographi
previous
describ
protein
concentr
determin
bradford
assay
use
bovin
serum
albumin
bsa
standard
dot
blot
analysi
protein
equal
concentr
tsp
plant
extract
ehcv
posit
control
nonagroinfiltr
plant
extract
directli
dot
nitrocellulos
membran
membran
dri
room
temperatur
block
wv
skim
milk
pbstween
vv
three
wash
step
incub
anticn
termin
antibodi
qiagen
tbst
two
hour
room
temperatur
follow
wash
step
membran
incub
dilut
horseradish
peroxidas
hrp
conjug
goat
antimous
antibodi
sigma
usa
one
hour
final
diaminobenzidin
dab
sigma
usa
use
color
develop
sdspage
western
blot
analys
purifi
hcv
core
e
coli
plant
plant
crude
extract
recombin
hcv
core
protein
express
coagroinfiltr
pvx
vector
load
onto
sdspolyacrylamid
gel
end
electrophoresi
protein
band
either
stain
coomassi
brilliant
blue
biorad
transfer
pvdf
membran
subsequ
correspond
protein
band
membran
identifi
biotinyl
anticor
polyclon
antibodi
abcam
uk
dilut
streptavidin
hrp
conjug
sigma
usa
dilut
respect
detect
tmb
substrat
elisa
perform
use
streptavidinbiotin
peroxidas
complex
abc
assay
briefli
well
coat
overnight
room
temperatur
mous
monoclon
antibodi
amino
acid
hcv
core
antigen
abcam
uk
block
bovin
serum
albumin
bsa
two
hour
sever
wash
step
tsp
sampl
ehcvcp
standard
curv
serial
dilut
rang
ad
coat
well
duplic
incub
one
hour
follow
wash
step
biotinyl
anticor
polyclon
antibodi
dilut
abcam
uk
immers
well
incub
continu
one
hour
follow
wash
step
anoth
similar
incub
streptavidin
hrp
conjug
sigma
final
ad
tmb
color
develop
absorb
nm
measur
detect
immunoreact
antigen
tobaccoderiv
hcvcp
indirect
elisa
detect
anticor
antibodi
human
sera
develop
previous
describ
brief
purifi
phcvcp
coat
elisa
plate
pool
human
sera
dilut
five
hcv
seroposit
patient
one
serum
neg
obtain
tehran
blood
transfus
center
incub
plate
two
hour
room
temperatur
hrplabel
antihuman
igg
dilut
sigma
usa
use
detect
bound
antibodi
tmb
use
color
develop
describ
prism
softwar
graphpad
usa
use
data
handl
statist
analysi
carri
use
nonparametr
anova
test
statist
signific
set
p
figur
repres
nucleotid
chang
appli
basal
sequenc
hcvcp
improv
codon
util
effici
express
plant
element
kozak
kedel
histag
restrict
site
also
includ
hcvcp
basal
sequenc
trhcvcp
figur
addit
remov
plant
mrna
destabil
sequenc
ggtaag
nucleotid
present
nativ
hcvcp
sequenc
modifi
figur
shown
figur
correspond
nucleotid
alter
increas
codon
adapt
index
cai
valu
reduc
gc
content
figur
b
result
dna
sequenc
shown
indic
kozak
gccaccatggc
sequenc
harbor
start
codon
atg
kdel
nucleotid
end
design
restrict
site
nucleotid
modif
properli
locat
trhcvcp
sequenc
figur
figur
repres
schemat
construct
pbicor
figur
pvxcore
figur
b
plant
express
vector
harbor
trhcvcp
locat
control
camv
promot
pbicor
cp
promot
pvxcore
upstream
noster
transcript
termin
sequenc
result
shown
confirm
presenc
clone
trhcvcp
gene
pbicor
pvxcore
express
vector
alter
nucleotid
result
plasmid
transfer
tumefacien
target
host
case
pvxcore
tumefacien
harbor
psoup
vector
transform
agrobacteria
screen
recombin
construct
use
corespecif
primer
fkozakvx
rcorevx
coloni
pcr
assay
indic
expect
fragment
figur
c
one
posit
clone
construct
subsequ
use
agroinfiltr
n
tabacum
leav
silencingsuppressor
gene
procedur
outlin
detect
analyz
phcvcp
transform
tobacco
leav
extract
evalu
dot
western
blot
assay
figur
shown
figur
dot
blot
analysi
show
hcv
core
present
extract
tobacco
leav
transform
vector
pbicor
pvxcore
compar
neg
control
amount
load
tsp
although
dot
blot
qualit
assay
rather
quantit
one
result
tent
impli
higher
level
express
pvxcore
compar
pbicor
construct
amount
tsp
appli
figur
coomassiestain
sdspage
show
nonspecificallybound
plant
protein
elut
ninta
affin
chromatographi
besid
band
electrophoret
mobil
kda
figur
b
recent
band
visibl
coomassiestain
sdspage
gel
figur
b
also
detect
use
anticor
polyclon
antibodi
western
blot
assay
degrad
phcvcp
protein
glycosyl
size
produc
protein
predict
protein
sequenc
http
shown
figur
c
result
western
blot
analysi
indic
phcvcp
pvxcore
pbicor
express
protein
approxim
kda
neg
control
lack
core
protein
ehcvcp
show
higher
molecular
weight
kda
due
addit
vectorderiv
amino
acid
plasmid
lowermolecular
weight
protein
band
presum
result
ribosom
releas
uncomplet
translat
previous
report
note
dot
blot
studi
perform
base
prior
studi
use
procedur
complement
western
blot
inde
western
blot
protein
complet
denatur
boil
sdspage
load
buffer
contain
sd
therefor
inform
might
relat
nativesolubl
structur
protein
might
lost
eg
interact
protein
conform
antibodi
dot
blot
assay
use
preliminari
fast
test
show
protein
express
express
level
phcvcp
vector
pbicor
classic
plant
binari
vector
pvxcore
viralbas
vector
presenc
absenc
coagroinfiltr
compar
elisa
sandwich
elisa
assay
choic
usual
quantif
antigen
protein
exact
precis
standard
curv
prepar
specif
antibodi
antigen
use
number
diagnost
elisa
kit
work
basi
context
perform
exact
precis
quantit
elisa
use
specif
monoclon
antibodi
core
antigen
bottom
elisa
plate
polyclon
anticor
antibodi
top
phcvcp
sandwich
elisabas
protocol
also
prepar
precis
standard
curv
appli
serial
dilut
data
shown
purifi
ehcvcp
calcul
express
level
phcvcp
express
form
percentag
tsp
determin
use
bradford
protein
assay
leav
transform
pvx
vector
without
hcvcp
coagroinfiltr
construct
use
neg
control
figur
result
indic
express
pbicor
pvxcore
around
tsp
absenc
coagroinfiltr
wherea
presenc
express
level
pbicor
pvxcore
increas
ngg
ngg
tsp
fresh
leaf
weight
respect
almost
five
time
improv
phcvcp
express
figur
diagnosi
potenc
phcvcp
detect
hcvinfect
human
sera
also
analyz
elisa
shown
figur
b
purifi
phcvcp
could
detect
hcvinfect
sera
compar
way
ehcvcp
primari
object
present
studi
provid
effici
transient
tobacco
system
express
hcvcp
regionallyadapt
tobacco
host
iranian
jafarabaditobacco
plant
cultivar
tobacco
plant
australian
nicotiana
speci
n
benthamiana
wellknown
hypersuscept
host
plantderiv
recombin
protein
express
knowledg
prior
report
avail
express
jafarabadi
tobacco
cultivar
one
current
avail
tobacco
cultivar
iran
address
concern
first
strategi
consid
would
optim
gene
sequenc
effici
codon
usag
plant
agreement
recent
shown
plant
codonoptim
li
gene
product
increas
significantli
comparison
unmodifi
counterpart
shown
figur
codon
optim
approach
increas
cai
valu
favor
codon
util
n
tabacum
although
increas
cai
valu
usual
inevit
accompani
increas
percentag
enhanc
mrna
instabl
decreas
effici
translat
codon
optim
approach
base
codon
usag
nuclearencod
gene
tobacco
could
keep
percentag
reduc
gc
content
figur
b
almost
perfect
rang
desir
gc
content
amelior
express
level
insert
kozak
sequenc
gccaccatggc
translat
start
site
atg
also
consid
figur
howev
sinc
two
base
pair
immedi
follow
atg
start
codon
c
compat
optim
kozak
sequenc
underlin
nucleotid
consist
approach
undertaken
amani
et
al
insert
gct
sequenc
code
alanin
nonpolar
amino
acid
moreov
improv
stabil
phcvcp
kdelencod
base
also
consid
site
trhcvcp
sequenc
figur
employ
strategi
express
human
epiderm
growth
factor
tobacco
result
higher
yield
protein
express
final
codon
optim
strategi
possibl
deleteri
splice
motif
plant
ggtaag
result
rna
degrad
gene
silenc
gene
remov
nativ
hcvcpcode
sequenc
nucleotid
studi
two
kind
plant
vector
employ
classic
nonrepl
binari
vector
pvxbase
viral
replic
vector
result
indic
pvxbase
vector
provid
higher
express
level
phcvcp
compar
figur
result
complet
agreement
result
recent
report
compar
express
level
tmv
pvx
replic
viral
vector
three
time
vector
obtain
highest
express
level
import
prevent
silenc
mechan
limit
foreign
gene
express
plant
shown
coexpress
viral
silenc
suppressor
protein
elimin
effect
posttranscript
gene
silenc
ptg
transient
express
system
applic
coagroinfiltr
alreadi
shown
improv
recombin
express
plant
sever
fold
result
indic
presenc
increas
express
level
phcvcp
five
time
pvx
express
construct
figur
data
consist
recent
report
enhanc
express
level
sarscov
n
antibodi
gfp
protein
presenc
even
fold
respect
time
differ
transient
express
level
human
growth
hormon
peptid
n
tabacum
tsp
studi
tsp
phcvcp
enhanc
express
level
studi
compar
prior
report
direct
result
codon
optim
gene
silenc
suppress
strategi
undertaken
trhcvcp
gene
modif
approach
final
result
elisa
studi
figur
demonstr
transient
express
phcvcp
tobacco
leav
could
provid
proper
protein
diagnost
purpos
indic
full
function
react
polymonoclon
anticor
antibodi
hcv
infect
human
sera
compar
ehcvcp
addit
proper
conform
phcvcp
interact
specif
monoclon
antibodi
amino
acid
core
antigen
coat
bottom
elisa
plate
polyclon
anticor
antibodi
top
phcvcp
elisa
support
presenc
variou
interact
epitop
phcvcp
monoclon
antibodi
use
studi
amino
acid
hcv
core
antigen
region
carri
two
import
immunolog
epitop
conserv
hcv
strain
moreov
amino
acid
highli
promiscu
cell
epitop
amino
acid
hcvspecif
ctl
epitop
shown
effect
immunogen
vaccin
phase
two
clinic
trial
present
hcv
core
particl
multiepitop
complex
therefor
primari
result
propos
plantproduc
phcvcp
might
promis
structur
use
vaccin
candid
howev
primari
result
confirm
anim
immun
studi
although
end
result
consist
prior
two
report
appropri
antigen
tobaccoderiv
hcvcp
previou
studi
address
transgen
stabl
tobaccopl
gener
hcvcp
howev
transient
express
plant
current
method
choic
due
simplic
feasibl
rapid
protein
express
omit
tissu
cultur
regener
cost
eas
larg
scale
industri
plan
growth
transgen
stabl
plant
gener
need
longer
period
transgen
product
deleteri
effect
gene
silenc
encount
transientexpress
approach
taken
togeth
present
studi
first
best
knowledg
address
construct
transient
tobacco
express
system
hcvcp
highest
possibl
express
effici
hcvcp
dna
sequenc
codon
optim
base
cai
nuclearencod
gene
tobacco
destabil
ggtaag
sequenc
nativ
hcvcp
code
sequenc
alter
kozak
kdel
sequenc
includ
end
respect
two
type
plant
express
vector
pvxbase
classic
binari
hcvcp
construct
level
protein
express
presenc
absenc
coagroinfiltr
compar
result
indic
signific
effect
approach
enhanc
express
level
phcvcp
knowledg
mention
report
first
kind
hcvcp
provid
valuabl
inform
plantbas
express
studi
antigen
preliminari
result
five
hcv
posit
sera
show
planthcvcp
capabl
captur
antihcvcp
antibodi
potenti
clinic
applic
evalu
confirm
statist
accept
number
posit
sampl
sera
next
step
might
standard
phcvcp
applic
diagnost
elisa
applic
posit
sera
determin
viral
load
well
precis
predetermin
standard
posit
sera
togeth
high
number
optim
studi
differ
concentr
antigenantibodi
elisa
precis
statist
analys
evalu
phcvcp
immun
studi
